These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34433901)

  • 1. Structural insights into ligand recognition and activation of the melanocortin-4 receptor.
    Zhang H; Chen LN; Yang D; Mao C; Shen Q; Feng W; Shen DD; Dai A; Xie S; Zhou Y; Qin J; Sun JP; Scharf DH; Hou T; Zhou T; Wang MW; Zhang Y
    Cell Res; 2021 Nov; 31(11):1163-1175. PubMed ID: 34433901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structures of active melanocortin-4 receptor-Gs-protein complexes with NDP-α-MSH and setmelanotide.
    Heyder NA; Kleinau G; Speck D; Schmidt A; Paisdzior S; Szczepek M; Bauer B; Koch A; Gallandi M; Kwiatkowski D; Bürger J; Mielke T; Beck-Sickinger AG; Hildebrand PW; Spahn CMT; Hilger D; Schacherl M; Biebermann H; Hilal T; Kühnen P; Kobilka BK; Scheerer P
    Cell Res; 2021 Nov; 31(11):1176-1189. PubMed ID: 34561620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the Allosteric Mechanism of Setmelanotide (RM-493) as a Potent and First-in-Class Melanocortin-4 Receptor (MC4R) Agonist To Treat Rare Genetic Disorders of Obesity through an in Silico Approach.
    Falls BA; Zhang Y
    ACS Chem Neurosci; 2019 Mar; 10(3):1055-1065. PubMed ID: 30048591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Key amino acid residue in Melanocortin-1 receptor (melanocyte α-MSH receptor) for ligand selectivity.
    Yang Y; Chen M; Ventro G; Harmon CM
    Mol Cell Endocrinol; 2017 Oct; 454():69-76. PubMed ID: 28579117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural insight into the MC4R conformational changes via different agonist-mediated receptor signaling.
    Yang Y; Chen M; Dimmitt R; Harmon CM
    Biochemistry; 2014 Nov; 53(45):7086-92. PubMed ID: 25347793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Complexity and Plasticity of Signaling Regulation at the Melanocortin-4 Receptor.
    Kleinau G; Heyder NA; Tao YX; Scheerer P
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32785054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural analysis of setmelanotide binding to MC4R variants in comparison to wild-type receptor.
    Hammad MM; Mohammad A; Alam-Eldin N; Madhu D; Al-Mulla F; Abu-Farha M; Abubaker J
    Life Sci; 2022 Oct; 307():120857. PubMed ID: 35931197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Key amino acid residues in the melanocortin-4 receptor for nonpeptide THIQ specific binding and signaling.
    Yang Y; Cai M; Chen M; Qu H; McPherson D; Hruby V; Harmon CM
    Regul Pept; 2009 Jun; 155(1-3):46-54. PubMed ID: 19303903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of 30 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists, synthetic agonists, and the endogenous agouti-related protein antagonist.
    Xiang Z; Proneth B; Dirain ML; Litherland SA; Haskell-Luevano C
    Biochemistry; 2010 Jun; 49(22):4583-600. PubMed ID: 20462274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans.
    Srinivasan S; Lubrano-Berthelier C; Govaerts C; Picard F; Santiago P; Conklin BR; Vaisse C
    J Clin Invest; 2004 Oct; 114(8):1158-64. PubMed ID: 15489963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist.
    Xiang Z; Litherland SA; Sorensen NB; Proneth B; Wood MS; Shaw AM; Millard WJ; Haskell-Luevano C
    Biochemistry; 2006 Jun; 45(23):7277-88. PubMed ID: 16752916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of MAPK by inverse agonists in six naturally occurring constitutively active mutant human melanocortin-4 receptors.
    Mo XL; Tao YX
    Biochim Biophys Acta; 2013 Dec; 1832(12):1939-48. PubMed ID: 23791567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, biophysical, and pharmacological evaluation of the melanocortin agonist AST3-88: modifications of peptide backbone at Trp 7 position lead to a potent, selective, and stable ligand of the melanocortin 4 receptor (MC4R).
    Singh A; Dirain ML; Wilczynski A; Chen C; Gosnell BA; Levine AS; Edison AS; Haskell-Luevano C
    ACS Chem Neurosci; 2014 Oct; 5(10):1020-31. PubMed ID: 25141170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning, tissue distribution, and pharmacological characterization of melanocortin-4 receptor in spotted scat, Scatophagus argus.
    Li JT; Yang Z; Chen HP; Zhu CH; Deng SP; Li GL; Tao YX
    Gen Comp Endocrinol; 2016 May; 230-231():143-52. PubMed ID: 27080551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the melanocortin-4 receptor structure identifies Ca
    Yu J; Gimenez LE; Hernandez CC; Wu Y; Wein AH; Han GW; McClary K; Mittal SR; Burdsall K; Stauch B; Wu L; Stevens SN; Peisley A; Williams SY; Chen V; Millhauser GL; Zhao S; Cone RD; Stevens RC
    Science; 2020 Apr; 368(6489):428-433. PubMed ID: 32327598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substituted NDP-MSH peptides paired with mutant melanocortin-4 receptors demonstrate the role of transmembrane 6 in receptor activation.
    Fleck BA; Ling N; Chen C
    Biochemistry; 2007 Sep; 46(37):10473-83. PubMed ID: 17713970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Signaling Profiles of MC4R Mutations with Three Different Ligands.
    Paisdzior S; Dimitriou IM; Schöpe PC; Annibale P; Scheerer P; Krude H; Lohse MJ; Biebermann H; Kühnen P
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of feline melanocortin 4 receptor and melanocortin 2 receptor accessory protein 2.
    Habara M; Mori N; Okada Y; Kawasumi K; Nakao N; Tanaka Y; Arai T; Yamamoto I
    Gen Comp Endocrinol; 2018 May; 261():31-39. PubMed ID: 29360464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Mechanistic and Pharmacodynamic Understanding of Melanocortin-4 Receptor Activation.
    Sharma S; Garfield AS; Shah B; Kleyn P; Ichetovkin I; Moeller IH; Mowrey WR; Van der Ploeg LHT
    Molecules; 2019 May; 24(10):. PubMed ID: 31100979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.